DUBLIN--(BUSINESS WIRE)--The "Growth Opportunities in Onco-Immunotherapy, Genetic Therapy, Synthetic Biology, Microbiome Therapeutics" report has been added to ResearchAndMarkets.com's offering. This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) focuses on advanced autologous and allogeneic cell therapies for cancers. It also covers developments in ADCs and small molecules for multiple cancers. Few innovations for inflammatory diseases and infectious diseases have also been highlighted in this issue. Therapies which leverage nanotechnology and engineered nanoparticles for drug protection and drug design complement these innovations. Synthetic biology innovations around low cost gene synthesis and deployment of gene circuits have been featured as well. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Tumor Microenvironment Targeted Therapies With An Improved Therapeutic Index Bioatla - Investor Dashboard
One-Time Curative Gene Therapy for Scd Autologus Cell Therapy for Advanced Melanoma
Car-T Cell Therapy With Enhanced Cell Proliferation Off-The-Shelf Car T-Cell Therapy
Allogeneic T-Cell Therapy Without Gene Editing
Off-The-Shelf Ebv-Targeting T-Cell Products
Tumor Prilferation Targeting Oral Kinase Inhibitor Small Molecule With Advanced Absorption, Distribution, Metabolism, and Excretion Properties
Macrophage Modifying Nanoparticle Platform With Anti Cancer Activity Technology Modulating Multiple Cell Types
Nanotechnology-Protected Enzymes to Survive in the Gastrointestinal Environment
Enhancing Enzyme Delivery Through Nanotechnology
Single Administration Orphan Drug With Us Fast-Track Designation
Tailoring Cell Behavior With Precision
Genetic Circuits That Provide Accurate Control Over Gene Programming
Asimov - Investor Dashboard
Understanding Gut Microbiomes and Their Interactions to Formulate Therapeutic Products
Gold Standard Customer Solution for Gene Synthesis
Benefits of Quick Turnover and Error-Free Sequencing
Eurofins Genomics Blue Heron - Investor Dashboard Metabolism Boosting Daily Wellness Supplements With Anti-Aging Benefits
Nmn Causing Nad+ to Activate Sir2 Gene to Boost Metabolic Efficiency Rapid Assay Delivering Accurate Results Comparable to Laboratory Tests
Technology Regulating Immune Cells Immunotherapy Leading to Sustained Therapeutic Responses
National Jewish Health's Technology Value Proposition
For more information about this report visit https://www.researchandmarkets.com/r/k1ljkq